Insulin-like growth factor (IGF) I mutant variants

Details for Australian Patent Application No. 2003236454 (hide)

Owner Genentech, Inc.

Inventors Lowman, Henry B; Dubaquie, Yves; Fielder, Paul J; Mortensen, Deborah L

Agent Griffith Hack

Pub. Number AU-B-2003236454

Parent 762351

Filing date 22 August 2003

Wipo publication date 18 September 2003

Acceptance publication date 6 April 2006

International Classifications

C07K 14/65 (2006.01) Peptides having more than 20 amino acids

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 5/02 (2006.01) Drugs for disorders of the endocrine system

Event Publications

11 September 2003 Complete Application Filed

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003236454

6 April 2006 Application Accepted

  Published as AU-B-2003236454

3 August 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236455-A fluid-operated torque tool

2003236453-Server and method for short message service in private wireless network interworking with public land mobile network